These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38715790)
1. LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients. Eltorky H; AbdelMageed M; Ismail H; Zahran F; Guirgis A; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Front Oncol; 2024; 14():1393075. PubMed ID: 38715790 [TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients. AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Ismail HTH; AbdelMageed M; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562947 [TBL] [Abstract][Full Text] [Related]
4. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome. AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131 [TBL] [Abstract][Full Text] [Related]
5. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511 [TBL] [Abstract][Full Text] [Related]
7. Distinct expression profile of stem cell markers, LGR5 and LGR6, in basaloid skin tumors. Jang BG; Lee C; Kim HS; Shin MS; Cheon MS; Kim JW; Kim WH Virchows Arch; 2017 Mar; 470(3):301-310. PubMed ID: 28070642 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer]. Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531 [No Abstract] [Full Text] [Related]
9. Prognostic factors in patients with high-risk stage II colon cancer after curative resection: a post hoc analysis of the JFMC46-1201 trial. Sugimoto K; Sakamoto K; Tsuchiya T; Takahashi T; Ohge H; Sato T; Taguri M; Morita S; Sadahiro S Int J Colorectal Dis; 2023 Oct; 38(1):260. PubMed ID: 37903983 [TBL] [Abstract][Full Text] [Related]
10. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer. Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711 [TBL] [Abstract][Full Text] [Related]
11. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer. Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296 [TBL] [Abstract][Full Text] [Related]
12. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
14. LGR6 is a potential diagnostic and prognostic marker for esophageal squamous cell carcinoma. Chai T; Shen Z; Zhang Z; Chen S; Gao L; Zhang P; Lin W; Kang M; Lin J J Clin Lab Anal; 2020 Apr; 34(4):e23121. PubMed ID: 31917882 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer. Li X; Xiong Z; Xie M; Huang Q; Jin L; Yin S; Chen S; Lan P; Lian L J Gastrointest Oncol; 2021 Aug; 12(4):1470-1481. PubMed ID: 34532103 [TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients. Lind GE; Guriby M; Ahlquist T; Hussain I; Jeanmougin M; Søreide K; Kørner H; Lothe RA; Nordgård O Clin Epigenetics; 2017; 9():97. PubMed ID: 28878843 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients. Rot S; Kaune T; Taubert H; Greither T; Kotrba J; Güttler A; Wichmann H; Bilkenroth U; Wienke A; Al-Nawas B; Bache M; Vordermark D; Wickenhauser C; Bethmann D; Eckert AW; Kappler M BMC Cancer; 2019 Feb; 19(1):155. PubMed ID: 30770730 [TBL] [Abstract][Full Text] [Related]
18. Single Lgr5- or Lgr6-expressing taste stem/progenitor cells generate taste bud cells ex vivo. Ren W; Lewandowski BC; Watson J; Aihara E; Iwatsuki K; Bachmanov AA; Margolskee RF; Jiang P Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16401-6. PubMed ID: 25368147 [TBL] [Abstract][Full Text] [Related]
19. Canine Epithelial Skin Tumours: Expression of the Stem Cell Markers Lgr5, Lgr6 and Sox9 in Light of New Cancer Stem Cell Theories. Bongiovanni L; Brachelente C; Moreno E; Welle MM Vet Sci; 2020 May; 7(2):. PubMed ID: 32397255 [TBL] [Abstract][Full Text] [Related]
20. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker. Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]